Pigs and Minipigs in Biomedical Research
In biomedical research, pigs and minipigs serve identical roles as animal models, particularly due to their physiological and anatomical similarities to humans. However, significant differences between them influence their specific applications, ease of handling, and ethical considerations in laboratory settings. Standard pigs (such as domestic farm breeds) grow quite large, typically reaching weights of 300–500 kg. Minipigs, such as the Göttingen, Yucatan, and Sinclair breeds, have been selectively bred to remain smaller, generally weighing between 30–70 kg as adults. Their smaller size makes them more practical and cost-effective to house in research facilities, and they are easier for researchers to handle during studies.
Pigs are often used when larger organ or tissue samples are needed, or in studies where their rapid growth may be an asset. Minipigs maintain a high level of genetic uniformity, an advantage in clinical research because it reduces variability in study results. Minipigs also have a slower growth rate which is beneficial for long-term studies where consistency in physiology over time is important.
Standard pigs are frequently used in agricultural and veterinary studies, as well as in large-scale preclinical studies where a human-equivalent organ size is required, such as in cardiovascular, orthopedic, and gastrointestinal research. Minipigs are primarily used in human biomedical research, including toxicology, pharmacology, and dermatology. Their skin structure is closer to human skin, making them ideal for dermatological studies, wound healing, and drug delivery research.
Pigs/Minipigs PBMCs

Similarity to Human Immune System
Pig/minipig PBMCs share similarities with human immune cells in terms of cellular composition, which makes them consequential for studying immune responses to predict human immune system functions.

Model for Translational Studies
Pig/minipig PBMCs serve as a robust model for evaluating immune system reactions in drug testing, immunotherapy, and vaccine development, helping to predict responses in humans more accurately than rodent models.

Compatibility with Human Genome
The pig/minipig genome is closely related to the human genome, meaning gene expression studies using pig/minipig PBMCs are more translatable to human genetics, facilitating studies in gene expression and immune modulation.

Ethical and Easy to Source
Pigs and minipigs can be bred and maintained in controlled environments, and their PBMCs are easier to source than human PBMCs, providing a more ethical and readily available resource for large-scale studies.

Reduced Need for Whole-Animal Testing
In vitro studies with pig/minipig PBMCs can reduce the need for full-scale animal testing, as PBMCs provide a more ethical, cost-effective way to assess immune functions and drug effects.

Standardized Techniques and Protocols
Beagles are widely used in research, thus beagle PBMCs offer an ethical alternative to intrusive whole-animal experiments. Since beagles are easy to collect samples from due to their calm temperament, a steady supply of PBMCs for long-term studies is an advantage.

In Vitro Modeling for Personalized Medicine
By culturing pig/minipig PBMCs in vitro, researchers can model cellular responses to drugs, immune challenges, and genetic modifications, facilitating advancements in personalized medicine and immunotherapy.
Want to learn more?
To learn more or inquire about Pig / Minipig PBMCs, click here!
PIG/MINIPIG PBMC Preparation

Animal Blood Collection

Dilution of Blood

Density Gradient Centrifugation

Collection of PBMC Layer

Washing the PBMCs

Counting and Viability Assessment

Storage/Immediate Use
Alpaca PBMC-Based Assays
PBMCs are a versatile sample type in preclinical research due to their role in the immune system. Assays using PBMCs help assess immune function, response to therapies, and disease pathophysiology.
Animal PBMCs are also commonly used in preclinical Safety, Toxicology and Translational research to help select the right in vivo model for late preclinial studies.
The following are common PBMC-based assays in preclinical research.

Flow Cytometry
This assay quantifies and analyzes various immune cell subsets within PBMCs, such as T cells, B cells, NK cells, and monocytes. Flow cytometry is widely used to determine immune status in diseases like HIV or cancer, evaluate immune responses to therapies, and track cell phenotypes in clinical trials.

ELISPOT (Enzyme-Linked Immunospot) Assay
ELISPOT measures the frequency of cytokine-secreting cells, indicating immune activation. It is often used in vaccine trials or infectious disease research to assess cellular immune responses by quantifying cytokines like IFN-γ, which indicates T-cell activation.

Proliferation Assays
These assays measure the ability of PBMCs to proliferate in response to specific antigens or mitogens. They are used in immunological research to assess immune responsiveness in autoimmune diseases, vaccine trials, or immunodeficiencies. Proliferation assays help determine immune system activation and potential deficiencies in cell-mediated immunity.

Intracellular Cytokine Staining (ICS)
ICS is used to detect cytokine production within individual cells using flow cytometry. This assay helps identify specific functional responses, such as Th1, Th2, or Th17 responses, by measuring cytokines like IL-2, IFN-γ, and TNF. It’s particularly valuable in vaccine and immunotherapy studies.
Published Study That Used Alpaca PBMCs
The study by Pernold et al. (2024) titled “Species comparison: human and minipig PBMC reactivity under the influence of immunomodulating compounds in vitro,” explores the use of minipigs as a translational model for studying immune responses and drug effects, given their physiological and immunological similarities to humans. The research focuses on peripheral blood mononuclear cells (PBMCs) from humans and Göttingen minipigs, examining their reactivity to immunomodulatory compounds through T-cell proliferation assays.
Key Highlights of Beagle PBMCs

T-cell Responses
CD4+ T cells showed higher activation in humans, while CD8+ T cells were more abundant in minipigs.

Drug Effects
Immunosuppressive drugs (abatacept, belatacept, rapamycin, and tofacitinib) showed species-specific responses. For instance, abatacept significantly reduced T-cell proliferation in minipigs compared to belatacept, highlighting differences in drug efficacy due to species-specific molecular interactions

Stimuli Dependency
The suppressive effects of drugs varied with the type of stimulation (e.g., concanavalin A, phytohemagglutinin-L, and staphylococcal Enterotoxin B).

Antigen-Specific Restimulation
- In minipigs immunized against porcine circovirus 2, all drugs reduced proliferative responses, with rapamycin being most effective.
- This research underlines the relevance of minipigs as a model for studying immune-modulating drugs and emphasizes the importance of tailoring stimuli and conditions for accurate interspecies comparisons in drug development.